Professor John Shine AC BSc (Hons 1) PhD DSc (Honoris Causa) PresAA
Professor Shine was Executive Director of the Garvan Institute of Medical Research from 1990 until the end of 2011 and is Professor of Medicine and Professor of Molecular Biology at the University of NSW and current Chairman of CSL Limited. He is a past Chairman of the National Health and Medical Research Council, past president of the Australian Genome Research Facility, and President of the Australian Academy of Science. He is a Companion in the Order of Australia and until 2011 a member of the Prime Minister’s Science, Engineering and Innovation Council. Until mid 2016 he was President of the Museum of Applied Arts and Science (Powerhouse Museum and Sydney Observatory).
Professor Shine obtained his PhD from the Australian National University in 1975. During 1975-1978 at the University of California, San Francisco, Professor Shine was instrumental in the development of many of the techniques of genetic engineering. He was a central figure in the cloning of the insulin and growth hormone genes and was the first to clone a human gene. He also determined the first sequence responsible for replication of a cancer causing virus.
In early 1984, Professor Shine was appointed Director of Research of a newly formed biotech company, California Biotechnology Inc. He was appointed President of the company in 1986 and guided it from a staff of some 15 scientists in 1984 to over 200 in 1987.
In 2010, Professor Shine was awarded the Prime Minister’s Prize for Science, the nation’s highest scientific award and in 2018 was elected President of the Australian Academy of Science.
Professor Shine was made a Companion (AC) in the General Division of the Order of Australia in the Queen’s Birthday Honours List 2017 for eminent service to medical research.
Professor Shine is a member of the QIMR Berghofer Appointments and Promotions Committee and the Commercialisation Committee.